Remnant Cholesterol Inflammatory Index Predicts Major Adverse Cardiovascular Events in Patients with Heart Failure with Preserved Ejection Fraction

Background: Heart failure with preserved ejection fraction (HFpEF) is linked to cardiometabolic dysregulation and systemic inflammation. The remnant cholesterol inflammatory index (RCII) integrates remnant cholesterol and high-sensitivity C-reactive protein (hs-CRP), but its prognostic relevance in HFpEF is unknown. Methods: This single-center retrospective cohort study included 324 adults hospitalized with HFpEF between March 2022 and May 2026. RCII was calculated as remnant cholesterol (mg/dL) × hs-CRP (mg/L)/10 and log-transformed. The primary endpoint was the first occurrence of all-cause death or HF rehospitalization, termed major adverse cardiovascular events (MACEs) in this study. Associations were assessed by multivariable Cox regression and restricted cubic splines. Incremental value was quantified using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Over a median follow-up of 24.1 months, 84 patients (25.9%) experienced MACE. Each 1-standard deviation increase in ln(RCII) was associated with the endpoint after adjustment for the measured covariates (adjusted HR, 1.80; 95% CI, 1.38–2.35; p < 0.001), and the highest tertile carried an approximately fourfold higher risk than the lowest (HR, 3.87; 95% CI, 2.02–7.39). The association was graded, without evidence of nonlinearity. Time-dependent AUCs for RCII were 0.655, 0.656, and 0.603 at 12, 24, and 30 months. Adding ln(RCII) raised the C-index of the clinical model from 0.707 to 0.736 (p = 0.040), with improved NRI but no statistically significant IDI improvement. Estimates were similar across 13 exploratory sensitivity analyses, but RCII correlated strongly with hs-CRP (ρ = 0.918) and their prognostic information overlapped substantially. Conclusions: Higher RCII was associated with MACE in HFpEF after adjustment for the measured covariates and provided modest incremental discrimination beyond the clinical model. Superiority over hs-CRP was not demonstrated, and external validation is required.

Authors

Institutions

Publication Details

Journal
Journal of Cardiovascular Development and Disease
Published
2026-11-18
DOI
https://doi.org/10.3390/jcdd13110607
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Remnant Cholesterol Inflammatory Index Predicts Major Adverse Cardiovascular Events in Patients with Heart Failure with Preserved Ejection Fraction

Mengchao Jin, Jiapeng Chu, Qiucheng Tao, Jiayu Yin et al.
6 links
Journal of Cardiovascular Development and Disease
Heart Failure Treatment and Management
article

Remnant Cholesterol Inflammatory Index Predicts Major Adverse Cardiovascular Events in Patients with Heart Failure with Preserved Ejection Fraction

Mengchao Jin, Jiapeng Chu, Qiucheng Tao, Jiayu Yin, Hui Li, Siliang Peng
article en

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF) is linked to cardiometabolic dysregulation and systemic inflammation. The remnant cholesterol inflammatory index (RCII) integrates remnant cholesterol and high-sensitivity C-reactive protein (hs-CRP), but its prognostic relevance in HFpEF is unknown. Methods: This single-center retrospective cohort study included 324 adults hospitalized with HFpEF between March 2022 and May 2026. RCII was calculated as remnant cholesterol (mg/dL) × hs-CRP (mg/L)/10 and log-transformed. The primary endpoint was the first occurrence of all-cause death or HF rehospitalization, termed major adverse cardiovascular events (MACEs) in this study. Associations were assessed by multivariable Cox regression and restricted cubic splines. Incremental value was quantified using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Over a median follow-up of 24.1 months, 84 patients (25.9%) experienced MACE. Each 1-standard deviation increase in ln(RCII) was associated with the endpoint after adjustment for the measured covariates (adjusted HR, 1.80; 95% CI, 1.38–2.35; p < 0.001), and the highest tertile carried an approximately fourfold higher risk than the lowest (HR, 3.87; 95% CI, 2.02–7.39). The association was graded, without evidence of nonlinearity. Time-dependent AUCs for RCII were 0.655, 0.656, and 0.603 at 12, 24, and 30 months. Adding ln(RCII) raised the C-index of the clinical model from 0.707 to 0.736 (p = 0.040), with improved NRI but no statistically significant IDI improvement. Estimates were similar across 13 exploratory sensitivity analyses, but RCII correlated strongly with hs-CRP (ρ = 0.918) and their prognostic information overlapped substantially. Conclusions: Higher RCII was associated with MACE in HFpEF after adjustment for the measured covariates and provided modest incremental discrimination beyond the clinical model. Superiority over hs-CRP was not demonstrated, and external validation is required.

Journal of Cardiovascular Development and DiseaseVol. 13(11)
Soochow University (CN), Zhongda Hospital Southeast University (CN), Second Affiliated Hospital of Soochow University (CN), Southeast University (CN)
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon